Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

217 Views

043. Clinical Trials: Thursday, 12:15 - 1:30 p.m.

Poster Session: Clinical Trials

(367) Safety and Immunogenicity of a 50-μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Adolescents

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

AF

Amparo Figueroa, MD, MPH (she/her/hers)

Director, Clinical Development - Infectious Diseases
Moderna, Inc.
Cambridge, Massachusetts, United States

Co-Author(s)

KA

Kashif Ali, MD

Kool Kids Pediatrics, DM Clinical Research
Houston, Texas, United States
GB

Gary Berman, MD

Clinical Research Institute, Allergy and Immunology
Minneapolis, Minnesota, United States
HZ

Honghong Zhou, Ph.D.

Moderna, Inc.
Cambridge, Massachusetts, United States
WD

Weiping Deng, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
MP

Monali Patel, MS

Moderna, Inc.
Cambridge, Massachusetts, United States
BG

Bethany Girard, Ph.D.

Moderna, Inc.
Cambridge, Massachusetts, United States
AY

Anne Yeakey, MD

Moderna, Inc.
Cambridge, Massachusetts, United States
KS

Karen Slobod, MD

Moderna, Inc.
Cambridge, Massachusetts, United States
FP

Frances Priddy, MD, MPH

Moderna, Inc.
Cambridge, Massachusetts, United States
JM

Jacqueline Miller, MD

Moderna, Inc.
Cambridge, Massachusetts, United States
RD

Rituparna Das, M.D.

Moderna, Inc.
Cambridge, Massachusetts, United States